Impact of novel prebiotic galacto-oligosaccharides on various biomarkers of colorectal cancer in wister rats

International Journal of Molecular Sciences

Volumn 18, Issue 9, 2017, Pages

  Qamar, Tahir Rasool ^a   Iqbal, Sanaullah ^a   Syed, Fatima ^a   Nasir, Muhammad ^a   Rehman, Habib ^a   Iqbal, Muhammad Aamir ^a   Liu, Rui Hai ^b  

^a UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

^b Cornell University ^*  (United States)

Author keywords

Aberrant crypt foci; Bacterial enzymes; Colorectal cancer; Galacto oligosaccharides

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETIC ACID; AZO REDUCTASE; BACTERIAL ENZYME; BETA GLUCOSIDASE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; BUTYRIC ACID; GALACTOSE OLIGOSACCHARIDE; INULIN; NITROREDUCTASE; PREBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; OLIGOSACCHARIDE; TUMOR MARKER;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; BIFIDOBACTERIUM; BODY WEIGHT; CLOSTRIDIA; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; ENTEROCOCCUS; ENZYME ACTIVITY; FECES ANALYSIS; LACTOBACILLUS; MALE; NONHUMAN; RAT; WEIGHT REDUCTION; ANIMAL; CHEMISTRY; COLORECTAL TUMOR; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; MALE; OLIGOSACCHARIDES; PREBIOTICS; RATS; RATS, WISTAR;

EID: 85028693865     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18091785     Document Type: Article

References (52)

1. Medicine, I.O. Opportunities in the Nutrition and Food Sciences: Research Challenges and the Next Generation of Investigators; The National Academies Press: Washington, DC, USA, 1994; p. 328.
2. Gibson, G.R.; Probert, H.M.; Loo, J.V.; Rastall, R.A.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17, 259–275. [CrossRef] [PubMed]
3. Ebert, M.N.; Beyer-Sehlmeyer, G.; Liegibel, U.M.; Kautenburger, T.; Becker, T.W.; Pool-Zobel, B.L. Butyrate induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxy-2-nonenal. Nutr. Cancer 2001, 41, 156–164. [CrossRef] [PubMed]
4. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417–1435. [CrossRef] [PubMed]
5. Petzelbauer, I.; Reiter, A.; Splechtna, B.; Kosma, P.; Nidetzky, B. Transgalactosylation by thermostable β-glycosidases from Pyrococcus furiosus and Sulfolobus solfataricus. Binding interactions of nucleophiles with the galactosylated enzyme intermediate make major contributions to the formation of new β-glycosides during lactose conversion. Eur. J. Biochem. 2000, 267, 5055–5066. [PubMed]
6. De Roode, B.M.; Franssen, M.C.; van der Padt, A.; Boom, R.M. Perspectives for the industrial enzymatic production of glycosides. Biotechnol. Prog. 2003, 19, 1391–1402. [CrossRef] [PubMed]
7. Janakiram, N.B.; Rao, C.V. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol. Sin. 2008, 29, 1–20. [CrossRef] [PubMed]
8. Tanaka, T. Colorectal carcinogenesis: Review of human and experimental animal studies. J. Carcinog. 2009, 8, 5. [CrossRef] [PubMed]
9. Benson, A.B., 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J. Manag. Care Pharm. 2007, 13, S5–S18. [CrossRef] [PubMed]
10. Davis, C.D.; Milner, J.A. Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 2009, 20, 743–752. [CrossRef] [PubMed]
11. Raju, J. Azoxymethane-induced rat aberrant crypt foci: Relevance in studying chemoprevention of colon cancer. World J. Gastroenterol. 2008, 14, 6632–6635. [CrossRef] [PubMed]
12. Namasivayam, N. Chemoprevention in experimental animals. Ann. N. Y. Acad. Sci. 2011, 1215, 60–71. [CrossRef] [PubMed]
13. Gupta, A.K.; Schoen, R.E. Aberrant crypt foci: Are they intermediate endpoints of colon carcinogenesis in humans? Curr. Opin. Gastroenterol. 2009, 25, 59–65. [CrossRef] [PubMed]
14. Bird, R.P.; Good, C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 2000, 112–113, 395–402. [CrossRef]
15. Khare, S.; Chaudhary, K.; Bissonnette, M.; Carroll, R. Aberrant crypt foci in colon cancer epidemiology. Methods Mol. Biol. 2009, 472, 373–386. [PubMed]
16. Fotiadis, C.I.; Stoidis, C.N.; Spyropoulos, B.G.; Zografos, E.D. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J. Gastroenterol. 2008, 14, 6453–6457. [CrossRef] [PubMed]
17. Femia, A.P.; Luceri, C.; Dolara, P.; Giannini, A.; Biggeri, A.; Salvadori, M.; Clune, Y.; Collins, K.J.; Paglierani, M.; Caderni, G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002, 23, 1953–1960. [CrossRef] [PubMed]
18. Verma, A.; Shukla, G. Administration of prebiotic inulin suppresses 1, 2-dimethylhydrazine dihydrochloride induced procarcinogenic biomarkers fecal enzymes and preneoplastic lesions in early colon carcinogenesis in Sprague Dawley rats. J. Funct. Foods 2013, 5, 991–996. [CrossRef]
19. Dias, M.C.; Vieiralves, N.F.; Gomes, M.I.; Salvadori, D.M.; Rodrigues, M.A.; Barbisan, L.F. Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis. Food Chem. Toxicol. 2010, 48, 772–780. [CrossRef] [PubMed]
20. Wijnands, M.V.; Appel, M.J.; Hollanders, V.M.; Woutersen, R.A. A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: Fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds. Carcinogenesis 1999, 20, 651–656. [CrossRef] [PubMed]
21. Wijnands, M.V.; Schoterman, H.C.; Bruijntjes, J.B.; Hollanders, V.M.; Woutersen, R.A. Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats. Carcinogenesis 2001, 22, 127–132. [CrossRef] [PubMed]
22. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74–108. [CrossRef] [PubMed]
23. Donini, L.M.; Serra-Majem, L.; Bullo, M.; Gil, A.; Salas-Salvado, J. The Mediterranean diet: Culture, health and science. Br. J. Nutr. 2015, 113, S1–S3. [CrossRef] [PubMed]
24. Macfarlane, G.T.; Macfarlane, S. Fermentation in the human large intestine: Its physiologic consequences and the potential contribution of prebiotics. J. Clin. Gastroenterol. 2011, 45, S120–S127. [CrossRef] [PubMed]
25. Sivieri, K.; Spinardi-Barbisan, A.L.T.; Barbisan, L.F.; Bedani, R.; Pauly, N.D.; Carlos, I.Z.; Benzatti, F.; Vendramini, R.C.; Rossi, E.A. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. Eur. Food Res. Technol. 2008, 228, 231–237. [CrossRef]
26. Gallaher, D.D.; Khil, J. The effect of synbiotics on colon carcinogenesis in rats. J. Nutr. 1999, 129, 1483S–1487S. [PubMed]
27. Reddy, B.S. Prevention of colon cancer by pre-and probiotics: Evidence from laboratory studies. Br. J. Nutr. 1998, 80, S219–S223. [PubMed]
28. Aachary, A.A.; Gobinath, D.; Srinivasan, K.; Prapulla, S.G. Protective effect of xylooligosaccharides from corncob on 1, 2-dimethylhydrazine induced colon cancer in rats. Biol. Carbohydr. Diet. Fiber 2015, 5, 146–152. [CrossRef]
29. Wang, S.; Zhu, H.; Lu, C.; Kang, Z.; Luo, Y.; Feng, L.; Lu, X. Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals. J. Dairy Sci. 2012, 95, 4813–4822. [CrossRef] [PubMed]
30. Weir, T.L.; Manter, D.K.; Sheflin, A.M.; Barnett, B.A.; Heuberger, A.L.; Ryan, E.P. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE 2013, 8, e70803. [CrossRef] [PubMed]
31. Pool-Zobel, B.L.; Sauer, J. Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans. J. Nutr. 2007, 137, 2580S–2584S. [PubMed]
32. Hijova, E.; Szabadosova, V.; Stofilova, J.; Hrckova, G. Chemopreventive and metabolic effects of inulin on colon cancer development. J. Vet. Sci. 2013, 14, 387–393. [CrossRef] [PubMed]
33. Hijova, E.; Szabadosova, V.; Strojny, L.; Bomba, A. Changes chemopreventive markers in colorectal cancer development after inulin supplementation. Bratisl. Lek. Listy 2014, 115, 76–79. [CrossRef] [PubMed]
34. Scharlau, D.; Borowicki, A.; Habermann, N.; Hofmann, T.; Klenow, S.; Miene, C.; Munjal, U.; Stein, K.; Glei, M. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res. 2009, 682, 39–53. [CrossRef] [PubMed]
35. Wong, C.S.; Sengupta, S.; Tjandra, J.J.; Gibson, P.R. The influence of specific luminal factors on the colonic epithelium: High-dose butyrate and physical changes suppress early carcinogenic events in rats. Dis. Colon Rectum. 2005, 48, 549–559. [CrossRef] [PubMed]
36. Goldin, B.R.; Gorbach, S.L. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Inst. 1976, 57, 371–375. [CrossRef] [PubMed]
37. Juśkiewicz, J.; Wróblewska, M.; Jarosławska, J.; Baliński, P.; Matusevičius, P.; Zduńczyk, P.; Zduńczyk, Z. Effects of inulin supplemented to cellulose-free or cellulose-rich diets on caecal environment and biochemical blood parameters in rats. J. Anim. Feed Sci. 2009, 18, 709–722. [CrossRef]
38. Lahouar, L.; Pochart, P.; Salem, H.B.; El Felah, M.; Mokni, M.; Magne, F.; Mangin, I.; Suau, A.; Pereira, E.; Hammami, M.; Achour, L. Effect of dietary fibre of barley variety ‘Rihane’ on azoxymethane-induced aberrant crypt foci development and on colonic microbiota diversity in rats. Br. J. Nutr. 2012, 108, 2034–2042. [CrossRef] [PubMed]
39. Suau, A.; Bonnet, R.; Sutren, M.; Godon, J.J.; Gibson, G.R.; Collins, M.D.; Dore, J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 1999, 65, 4799–4807. [PubMed]
40. Manning, T.S.; Gibson, G.R. Microbial-gut interactions in health and disease. Prebiotics. Best Pract. Res. Clin. Gastroenterol. 2004, 18, 287–298. [CrossRef] [PubMed]
41. Chadwick, R.W.; George, S.E.; Claxton, L.D. Role of the gastrointestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens. Drug. Metab. Rev. 1992, 24, 425–492. [CrossRef] [PubMed]
42. Tzortzis, G.; Goulas, A.K.; Gibson, G.R. Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain, Bifidobacterium bifidum NCIMB 41171. Appl. Microbiol. Biotechnol. 2005, 68, 412–416. [CrossRef] [PubMed]
43. Tzortzis, G.; Goulas, A.K.; Gee, J.M.; Gibson, G.R. A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J. Nutr. 2005, 135, 1726–1731. [PubMed]
44. Reeves, P.G.; Rossow, K.L.; Lindlauf, J. Development and testing of the AIN-93 purified diets for rodents: Results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr. 1993, 123, 1923–1931. [PubMed]
45. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659–661. [CrossRef] [PubMed]
46. Dias, M.C.; Spinardi-Barbisan, A.L.; Rodrigues, M.A.; de Camargo, J.L.; Teran, E.; Barbisan, L.F. Lack of chemopreventive effects of ginger on colon carcinogenesis induced by 1, 2-dimethylhydrazine in rats. Food Chem. Toxicol. 2006, 44, 877–884. [CrossRef] [PubMed]
47. Iqbal, S.; Nguyen, T.H.; Nguyen, T.T.; Maischberger, T.; Haltrich, D. β-Galactosidase from Lactobacillus plantarum WCFS1: Biochemical characterization and formation of prebiotic galacto-oligosaccharides. Carbohydr. Res. 2010, 345, 1408–1416. [CrossRef] [PubMed]
48. Splechtna, B.; Nguyen, T.-H.; Steinböck, M.; Kulbe, K.D.; Lorenz, W.; Haltrich, D. Production of prebiotic galacto-oligosaccharides from lactose using _-galactosidases from Lactobacillus reuteri. J. Agric. Food Chem. 2006, 54, 4999–5006. [CrossRef] [PubMed]
49. Bird, R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995, 93, 55–71. [CrossRef]
50. Qamar, T.R.; Syed, F.; Nasir, M.; Rehman, H.; Zahid, M.N.; Liu, R.H.; Iqbal, S. Novel combination of prebiotics galacto-oligosaccharides and inulin-inhibited aberrant crypt foci formation and biomarkers of colon cancer in wistar rats. Nutrients 2016, 8. [CrossRef] [PubMed]
51. Zhao, G.; Nyman, M.; Åke Jönsson, J. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed. Chromatogr. 2006, 20, 674–682. [CrossRef] [PubMed]
52. DeWiele, T.V.; Boon, N.; Possemiers, S.; Jacobs, H.; Verstraete, W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 2004, 51, 143–153. [CrossRef] [PubMed]